ATYR earnings date and last-quarter result: last quarter beat, P/E -0.67. Updated 2026-07-23.
aTyr Pharma (ATYR) Research Hub
aTyr Pharma (ATYR) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 0.1534 USD (-7.09%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.67, market cap 0.05B. This hub links to the full technical, earnings and options research available for ATYR.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.1534 USD (-7.09%) |
| 52-week range | 0.144 USD – 0.6998 USD |
| Trend regime | Range |
| 14-day RSI | 1.6 (Oversold) |
| Trailing P/E | -0.67 |
| Market cap | 0.05B |
| Dividend yield | 0.00% |
Available research for ATYR
Covered Call on ATYR: how it works, illustrative setup around the real 0.1534 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ATYR: how it works, illustrative setup around the real 0.1534 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ATYR: how it works, illustrative setup around the real 0.1534 USD price, max profit/loss, breakeven and when to use it. Educational.
ATYR technical analysis: range, last 0.1534 USD, RSI 1.6, 52w range 0.144 USD–0.6998 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is ATYR in?
aTyr Pharma (ATYR) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ATYR in an uptrend or downtrend?
As of 2026-10-26, ATYR is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ATYR's trailing P/E ratio?
ATYR's trailing P/E is -0.67, with a market cap of 0.05B. See the earnings research page for full valuation detail.